NSPR vs. SNWV, ZIMV, TCMD, NYXH, NVRO, DRTS, SKIN, CATX, BWAY, and LAKE
Should you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include SANUWAVE Health (SNWV), ZimVie (ZIMV), Tactile Systems Technology (TCMD), Nyxoah (NYXH), Nevro (NVRO), Alpha Tau Medical (DRTS), Beauty Health (SKIN), Perspective Therapeutics (CATX), BrainsWay (BWAY), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry.
InspireMD vs.
InspireMD (NYSE:NSPR) and SANUWAVE Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation, profitability and community ranking.
SANUWAVE Health has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. SANUWAVE Health's return on equity of 0.00% beat InspireMD's return on equity.
InspireMD currently has a consensus target price of $4.50, indicating a potential upside of 102.70%. Given InspireMD's stronger consensus rating and higher probable upside, equities research analysts plainly believe InspireMD is more favorable than SANUWAVE Health.
44.8% of InspireMD shares are held by institutional investors. Comparatively, 42.5% of SANUWAVE Health shares are held by institutional investors. 29.7% of InspireMD shares are held by insiders. Comparatively, 36.6% of SANUWAVE Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
InspireMD has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, SANUWAVE Health has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.
In the previous week, InspireMD had 1 more articles in the media than SANUWAVE Health. MarketBeat recorded 3 mentions for InspireMD and 2 mentions for SANUWAVE Health. InspireMD's average media sentiment score of 0.47 beat SANUWAVE Health's score of -0.07 indicating that InspireMD is being referred to more favorably in the media.
InspireMD received 5 more outperform votes than SANUWAVE Health when rated by MarketBeat users.
InspireMD has higher earnings, but lower revenue than SANUWAVE Health. SANUWAVE Health is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.
Summary
InspireMD beats SANUWAVE Health on 11 of the 17 factors compared between the two stocks.
Get InspireMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
InspireMD Competitors List
Related Companies and Tools
This page (NYSE:NSPR) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy NSPR Stock Free NSPR Stock Alerts